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Background: CD4+ memory T-cells are a major target for infection by HIV-1, whereby latent provirus can establish
and endure suppressive antiretroviral therapies. Although HIV-1 subtype C strains (C-HIV) account for the majority of
HIV-1 infections worldwide, the susceptibility of CD4+ memory T-cells to infection by CCR5- (R5) and CXCR4-using
(X4) C-HIV is unknown. Here, we quantified the susceptibility of naïve and memory CD4+ T-cell subsets, including
stem cell memory T-cells (TSCM), to infection by HIV-1 subtype C (C-HIV) strains from treatment-naïve subjects who
progressed from chronic to advanced stages of disease whilst either maintaining CCR5-using (R5) viruses (subjects
1503 and 1854), or who experienced emergence of dominant CXCR4-using (X4) strains (subject 1109).
Findings: We show that R5 and X4 C-HIV viruses preferentially target memory and naïve CD4+ T-cell subsets,
respectively. While TSCM were susceptible to infection by both R5 and X4 C-HIV viruses, the proportion of infected
CD4+ T-cells that were TSCM was higher for R5 strains. Mutagenesis studies of subject 1109 viruses established the
V3 region of env as the determinant underlying the preferential targeting of naïve CD4+ T-cells by emergent X4
C-HIV variants in this subject. In contrast, the tropism of R5 C-HIV viruses for CD4+ T-cell subsets was maintained
from chronic to advanced stages of disease in subjects 1503 and 1854.
Conclusions: This study provides new insights into the natural history of tropism alterations for CD4+ T-cell subsets
by C-HIV strains during progression from chronic to advanced stages of infection. Although not preferentially
targeted, our data suggest that TSCM and other memory CD4
+ T-cells are likely to be viral reservoirs in subjects with
X4 C-HIV infection.
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CD4+ T-cells are targets for infection by human im-
munodeficiency virus type 1 (HIV-1), whereby latent,
replication-competent provirus can persist despite suppres-
sive antiretroviral therapies [1]. Following exposure to anti-
gen, naïve CD4+ T-cells (TN) proliferate and differentiate
into antigen-specific effector cells or self-renewing memory
T-cells [2,3]. Memory CD4+ T-cell subsets include long-
lived central memory T-cells (TCM), transitional memory
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unless otherwise stated.[4,5]. Recently, a new memory T-cell subset was described
in CD4+ and CD8+ T-cell populations in humans [6-8].
These cells, termed stem cell memory T cells (TSCM),
account for approximately 2–4% of the CD4+ T-cell popu-
lation in HIV-seronegative individuals, and are the longest-
lived memory CD4+ T-cell subset [8,9]. Importantly, TSCM
contribute to the persistent cellular HIV-1 reservoir [6].
HIV-1 entry into cells is mediated by the interaction be-
tween the viral envelope protein complex (Env) and cell-
surface CD4, and then with a chemokine coreceptor, either
CCR5 or CXCR4 (reviewed in [10]). The ability of HIV-1
to engage CCR5, CXCR4 or either coreceptor for entry is a
major determinant of cellular tropism, and is used to clas-
sify viruses as R5, X4 or R5X4, respectively [11].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for >50% of HIV-1 infections worldwide and exhibit
pathogenicity and tropism alterations that are distinct
from other HIV-1 subtypes [12], at present there are few
studies describing the susceptibility of CD4+ T-cell sub-
sets to infection by clinical R5 C-HIV strains, and none
concerning clinical X4 C-HIV isolates. Given recent
reports that have described increased incidence of X4 C-
HIV strains across multiple cohorts, particularly from
patients with late-stage disease (up to 52%) [12-17], this
lack of knowledge has implications for HIV/AIDS cure
strategies, including the widely discussed use of histone
deacetylase inhibitors to activate transcription of latent
provirus and purge CD4+ memory T-cell reservoirs.
Since changes in HIV-1 cellular tropism may influence
the size and composition of viral reservoirs, here we
sought to quantify and compare the susceptibility of
naïve and memory CD4+ T-cell subsets, including TSCM,
to infection by clinical X4 and R5 C-HIV strains from
patients who either maintained R5 viruses or experienced
emergence of X4 strains during progression from chronic
to advanced stages of C-HIV infection.
Experimental procedures
We utilized X4 (n = 2) and R5 (n = 15) Envs cloned
from longitudinal plasma samples of three treatment-
naïve C-HIV infected subjects (1503, 1854 and 1109)
from the recently described MUSH cohort [12] who,
over a 3-year sampling period, showed clinical and im-
munological evidence of progression from chronic to
advanced stages of infection [12,17] (Table 1). Subjects
1503 and 1854 exclusively harboured R5 viruses in
plasma samples provided at enrolment (E), 1-year later
(I; intermediate) and 3-years after enrolment (F; final),
whereas subject 1109 experienced a switch from dom-
inant R5 viruses in enrolment and intermediate plasma
samples to dominant X4 strains in the final plasma
sample [12] (Table 1).
To determine the CD4+ T-cell subset tropism for each of
these Envs, we utilized an in vitro multi-parameter flow
cytometry-based infection assay, described in our recent
studies [18,19] and in Additional file 1. Briefly, peripheral
blood CD4+ T-cells isolated from four HIV-seronegative
donors were infected with single-round Env-pseudotyped
GFP reporter viruses, then HIV-1 infection was determined
by GFP positivity and the distribution of infection among
CD4+ T-cell subsets was determined using antibodies









(CD45RO−CCR7−CD27−) The fluorochrome labeled flow
cytometry antibodies used in this study are described in
Additional file 1: Table S1. Our T-cell subset gatingstrategy, which we have described previously [18], is illus-
trated in Additional file 1: Figure S1.
GFP reporter viruses pseudotyped with well-
characterized T-cell tropic B-HIV Envs JR-CSF (R5),
HXB2 (X4) and Macs1-Spleen12 (R5X4) were used as con-
trols [19-22]. CD4+ T-cells were infected with 3000 infec-
tious units of B- and C-HIV R5 viruses, and 1250
infectious units of B- and C-HIV R5X4 and X4 viruses,
which we determined here (data not shown) and previ-
ously [18,19] to be virus inoculums that ensure infections
within the linear range.
R5 and X4 C-HIV Envs exhibit alternative CD4+ T-cell
subset tropism profiles
Prior to infection we first showed that the proportion of
each CD4+ T-cell subset (Additional file 1: Figure S2)
and the proportion of cells expressing CCR5 and CXCR4
(Additional file 1: Table S2) was similar between donors,
and was consistent with the findings of previous studies
[10,18,19,23,24]. R5 C-HIV Envs mediated levels of CD4+
T-cell infection (mean 1% ± standard deviation 0.4% of in-
fected CD4+ T-cells) similar to JR-CSF (1 ± 0.1%), and pref-
erentially infected memory T-cells; TN (21.5 ± 8.9%), TSCM
(3.3 ± 2.6%), TCM (24.7 ± 5.3%), TTM (20.1 ± 4.7%), TEM
(14.9 ± 4.8%) and TEMRA (0.6 ± 0.4%) (Figure 1a). X4 C-
HIV Envs mediated levels of CD4+ T-cell infection (3.5 ±
1.8%) similar to HXB2 (1.7 ± 0.9%), and preferentially in-
fected naïve T-cells; TN (62.1 ± 12.1%), TSCM (1.1 ± 1.7%),
TCM (16.9 ± 7.3%), TTM (13.5 ± 4.6%), TEM (5.7 ± 2.8%) and
TEMRA (0.6 ± 0.7%), (Figure 1a). The preferential infection
of memory and naive T-cells by R5 and X4 C-HIV Envs, re-
spectively, could be influenced by the variation in the pro-
portion of cells that express CCR5 and CXCR4 (Additional
file 1: Table S2) as CD45RO− cells had a higher proportion
of CD4+ T-cells expressing CXCR4 compared to CD45RO+
cells, which had higher proportions of CD4+ T-cells ex-
pressing CCR5. Together, these data suggest that, within
these subjects, C-HIV tropism for CD4+ memory and naïve
T-cells is constrained by Env coreceptor specificity.
Env determinants underlying the linkage between C-HIV
coreceptor specificity and CD4+ T-cell tropism alterations
To better understand the underlying Env determinants of
C-HIV tropism for CD4+ T-cell subsets, we quantified the
susceptibility of CD4+ T-cells isolated from peripheral
blood of four HIV-seronegative donors to infection by GFP
reporter viruses pseudotyped with X4 1109-F-30 Env that
was mutated to express the V3 region of the R5 1109-E-10
Env (referred to as 1109-F-30-E10V3) (Additional file 1:
Table S3). Previously we utilized this Env to define the cri-
tical C-HIV V3 alterations necessary to confer CXCR4
usage [12,18]. In these studies, we confirmed that either an
Ile314-Gly315 insertion or an Arg318Pro alteration in the
V3 loop crown (GPGQ) motif was sufficient to confer an












1503 E 396 5.73 11 R5
13 R5
I 168 5.69 7 R5
11 R5
F 259 5.71 7 R5
8 R5
1854 E 435 5.61 8 R5
10 R5
I 279 6.57 4 R5
20 R5
F 272 5.67 4 R5
8 R5
1109 E 367 5.54 10 R5
42 R5
I 402 5.59 3 R5
F 169 5.67 30 X4
39 X4
- - - F-30-
E10V3
R5
The CD4+ T-cell counts and plasma viral loads for these subjects have been reported
previously, and are summarized again here to assist in the interpretation of the
CD4+ T-cell subset tropism data [12]. Plasma viral load values are shown as log10.
Envs were cloned directly from plasma samples provided at enrolment (E), 1-year
later (I; intermediate) and 3-years after enrolment (F; final). Env coreceptor usage
was determined by infecting NP2 or U87 cells expressing CD4 and either CCR5 or
CXCR4 with Env-pseudotyped luciferase reporter viruses [12]. The 1109-F-30-E10V3
Env was generated by mutating 1109-F-30 to express the V3 region of 1109-E-10
[12,17]. Env ID, HIV-1 Env identification number as described in [12].
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together conferred a strictly X4 phenotype. Here, the R5
1109-F-30-E10V3 Env displayed a CD4+ T-cell subset trop-
ism profile that was similar to enrolment and intermediate
1109 R5 Envs, preferentially infecting memory CD4+ T-
cells; TN (30.9 ± 17.2%), TSCM (2.1 ± 3.6%), TCM (26.4 ±
6.5%), TTM (24.4 ± 7.1%), TEM (15.9 ± 5.2%) and TEMRA
(0.4 ± 0.4%) (Figure 1a). These findings establish (i) the V3
loop as a key determinant of CD4+ T-cell subset tropism
for viruses from subject 1109, and (ii) the linkage between
C-HIV coreceptor specificity and CD4+ T-cell tropism
alterations.
V3 determinants of 1109-F-30 tropism for CD4+ T-cell
subsets are shared by the majority of CXCR4-using C-HIV
Envs
Our analyses of X4 C-HIV Envs were limited to just
subject 1109 because this was the only individual within
our longitudinal cohort to experience the emergence of
CXCR4-using strains [12]. To gauge the likelihood that
our findings would translate to other CXCR4-using C-HIV strains, we analyzed every previously published R5
(n = 1653) and CXCR4-using (n = 203) C-HIV Env se-
quence for expression of the defined 1109-F-30 V3 deter-
minants of CXCR4-usage and tropism for CD4+ T-cell
subsets, namely the two amino acid insertion at positions
314–315 and/or the GPGQ crown alteration. Additional
file 1: Table S4 shows that of the CXCR4-using V3 se-
quences, 27.1% contained a 314–315 insertion, of which
81.9% contained Ile314-Gly315 (36.5% overall), 62.6%
exhibited a GPGQ alteration, of which 55.1% exhibited
GRGQ (58.1% overall), and 23.2% contained both a 314–
315 insertion and a GPGQ alteration, of which 84.9%
exhibited both Ile314-Gly315 and GRGQ (32.4% overall).
These proportions were even higher when assessing just
strictly X4 C-HIV Envs, where 44.6% contained a 314–315
insertion, of which 81.8% contained Ile314-Gly315 (36.5%
overall), 83.8% exhibited a GPGQ alteration, of which
69.3% exhibited GRGQ (58.1% overall), and 39.2% con-
tained both a 314–315 insertion and a GPGQ alteration,
of which 82.7% exhibited both Ile314-Gly315 and GRGQ
(32.4% overall). Conversely, none of the R5 V3 sequences
contained a 314–315 insertion and only 1.9% exhibited a
GPGQ alteration (none of which were GRGQ). Although
further functional studies are required to establish the
CD4+ T-cell subset tropism properties of diverse CXCR4-
using C-HIV strains, these sequence analyses suggest that
a substantial proportion of previously reported X4 C-HIV
Envs will likely exhibit a similar profile to that of the X4
Envs from subject 1109.
TSCM are susceptible to infection by CCR5- and CXCR4-using
clinical C-HIV viruses
Recently, a new subset of CD4+ T-cells, TSCM, was found
to contribute significantly to the viral reservoir during
HIV-1 disease progression [6]. Here, we found that the
proportion of CD4+ T-cells infected by X4 C-HIV Envs
from subject 1109 that were TSCM (1 ± 1.4%) was signifi-
cantly less (by Mann Whitney test) than that of R5 C-
HIV strains from subject 1109 (3.7 ± 2.9%, p = 0.0165),
1503 (2.6 ± 2.6%, p = 0.0354) and 1854 (3.8 ± 2.4%, p =
0.0013) (Figure 1b). Unexpectedly, the proportion of
TSCM infected by the R5 1109-F-30-E10V3 Env (1.9 ±
3.2%) was statistically similar to both R5 and X4 C-HIV
isolates from subject 1109, suggesting that additional
mutations in the 1109-F-30 Env are required to confer
TSCM entry levels alike subject 1109 R5 Envs.
These results suggest that TSCM are more susceptible
to infection by R5 C-HIV clinical isolates than X4
strains. Future studies involving replication-competent
viruses are required to more accurately quantify the sus-
ceptibility of TSCM to infection by C-HIV in vivo. While
it is important to note that TSCM represent a small pro-
portion of the total circulating CD4+ T-cells and their
level of infection was relatively low, demonstration of
Figure 1 Proportion of CD4+ T-cell subsets infected by Env-pseudotyped GFP reporter viruses. (a) Values represent the percentage of
infected CD4+ T-cells that belong to the indicated subset; naïve (TN, dark blue), stem cell memory (TSCM, red), central memory (TCM, yellow), transitional
memory (TTM, light blue), effector memory (TEM, purple) and effector memory RA (TEMRA, green). Values were averaged across four HIV-seronegative
donors. Error bars represent the standard deviation. CD4+ T-cells were infected with GFP reporter viruses pseudotyped with (i) subtype C HIV-1 Envs
isolated from plasma samples of subjects 1503, 1854 and 1109 provided at enrolment (E), 1-year later (I; intermediate) and 3-years after enrolment
(F; final), or (ii) subtype B HIV-1 control Envs. Text in parentheses indicates the number of Envs isolated per plasma sample and/or Env coreceptor usage;
CCR5-specific (R5), CXCR4-specific (X4), uses CCR5 or CXCR4 (R5X4). (b) Values represent the percentage of infected CD4+ T-cells that are TSCM for each
Env-pseudotyped GFP reporter virus per donor (individual dots). Columns display the mean and standard deviation. Statistical analyses were performed
using Mann Whitney tests, p-values ≤0.05 were considered significant.
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nical C-HIV viruses provides new information that may
help inform the design and implementation of therapies
that target the TSCM HIV-1 reservoir, such as anti-cancer
drugs that block stem cell-specific molecular pathways
expressed by TSCM cells [25].
The susceptibility of CD4+ T-cell subsets to CCR5-mediated
infection is maintained during progression from chronic
and advanced C-HIV infection
To determine whether C-HIV CD4+ T-cell subset tropism
is altered during progression from chronic to advanced C-HIV infection, we performed intra-patient statistical ana-
lysis to compare the proportion of CD4+ T-cell subsets
infected by Envs cloned from enrolment, intermediate and
final time point plasma samples (Figure 1a). Statistical
significance (by Mann Whitney test) was only observed for
subject 1109 between Envs from the final time point and
Envs from enrolment (E) or intermediate (I) time points,
where the emergence of X4 strains was associated with
a significant increase in the proportion of infected CD4+
T-cells that were TN (E p = 0.0002, I p = 0.004), and a sig-
nificant decrease in the proportion of infected TCM (E p =
0.0002, I p = 0.0444), TTM (E p = 0.0002, I p = 0.004), TEM
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p = 0.0202).
Interestingly, these results suggest that as subjects
1503 and 1854 progressed from chronic to advanced C-
HIV infection over a 3 year period [12] (Table 1), circu-
lating R5 viruses maintained their tropism profiles for
CD4+ T-cell subsets. While additional studies involving
more C-HIV Envs isolated over longer periods of time
are required to confirm these findings, our data support
those from a study by Buzon et al. [6], which showed
that the susceptibility of TSCM to infection by R5 subtype
B HIV-1 is maintained during disease progression, and
those from a study by Chomont et al. [1], which showed
that HIV-1 can persist in TCM and TTM of subjects who
exhibit reconstitution of CD4+ T-cells during suppres-
sive antiretroviral therapy.
Conclusions
These findings provide new insights into the natural his-
tory of tropism alterations for CD4+ T-cell subsets by R5
and X4 C-HIV strains during progression from chronic
to advanced stages of infection. Specifically, we showed
that R5 C-HIV strains maintain their preference for in-
fecting memory CD4+ T-cell subsets during later stages
of C-HIV infection, whereas emergent X4 C-HIV strains
preferentially target TN. Furthermore, by demonstrating
the susceptibility of TSCM to infection by C-HIV, our re-
sults highlight the potential for this subset of CD4+ T-
cells to serve as a long-lived viral reservoir in individuals
harboring CCR5- and CXCR4-using C-HIV viruses.
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sequence accession numbers.
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